NCT05249569 2023-05-03Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular CarcinomaUniversity of Texas Southwestern Medical CenterPhase 2 Terminated1 enrolled 4 charts
NCT01210495 2019-01-09Axitinib For The Treatment Of Advanced Hepatocellular CarcinomaPfizerPhase 2 Completed224 enrolled 35 charts